Dixon Wendy L
SEC-identified person · CIK 1202283 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zevra Therapeutics, INC. ZVRA | Director | filed 2023 - 2025 |
| Black Diamond Therapeutics, Inc. BDTX | Director | filed 2022 - 2024 |
| Arvinas, INC. AVRN | Director | filed 2020 - 2023 |
| Alkermes plc. ALKS | Director | filed 2011 - 2022 |
| Lion Biotechnologies, Inc. N/A | Director | filed 2022 - 2022 |
| Incyte Corp INCY | Director | filed 2010 - 2022 |
| Bluebird bio, Inc. BLUE | Director | filed 2013 - 2021 |
| Voyager Therapeutics, Inc. VYGR | Director | filed 2017 - 2020 |
| Sesen Bio, Inc. SESN | Director | filed 2014 - 2019 |
| Orexigen Therapeutics, Inc. OREXQ | Director | filed 2010 - 2015 |
| Furiex Pharmaceuticals, Inc. FURX | Director | filed 2010 - 2014 |
| Intrabiotics Pharmaceuticals INC /DE RDEA | Director | filed 2011 - 2012 |
| Alkermes INC ALKS | Director | filed 2011 - 2011 |
| Dentsply Sirona Inc. XRAY | Director | filed 2007 - 2010 |
| Bristol Myers Squibb CO BMY | CMO & Pres, Global Marketing | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.